Biomarker profiles of endothelial activation and dysfunction in rare systemic autoimmune diseases: implications for cardiovascular risk

J Wienke, JS Mertens, S Garcia, J Lim… - …, 2021 - academic.oup.com
Objectives Vasculopathy is an important hallmark of systemic chronic inflammatory
connective tissue diseases (CICTD) and is associated with increased cardiovascular risk …

Patients with autoimmune chronic inflammatory diseases present increased biomarkers of thromboinflammation and endothelial dysfunction in the absence of flares …

P Anyfanti, E Gavriilaki, B Nikolaidou… - Journal of Thrombosis …, 2022 - Springer
Cardiovascular risk is increased in patients with autoimmune rheumatic diseases.
Endothelial, erythrocyte and platelet microvesicles (MVs) are elevated in patients with …

[HTML][HTML] Endothelial dysfunction in systemic lupus erythematosus and systemic sclerosis: A common trigger for different microvascular diseases

L Moschetti, S Piantoni, E Vizzardi, E Sciatti… - Frontiers in …, 2022 - frontiersin.org
Systemic autoimmune diseases are a group of disorders featured by humoral and cell-
mediated immune responses against several self-molecules. Despite the fact that diagnostic …

Serum levels of vascular dysfunction markers reflect disease severity and stage in systemic sclerosis patients

M Cossu, R Andracco, A Santaniello, M Marchini… - …, 2016 - academic.oup.com
Objective. To improve knowledge of vasculopathy in SSc through the assessment of serum
levels of circulating angiogenetic and endothelial dysfunction markers in patients at different …

Silent cardiovascular involvement in patients with diffuse systemic sclerosis: a controlled cross‐sectional study

M Turiel, L Gianturco, C Ricci… - Arthritis care & …, 2013 - Wiley Online Library
Objective An association between systemic autoimmune diseases and atherosclerosis has
been described in many connective tissue diseases, and this association is known to lead to …

Vascular biomarkers and correlation with peripheral vasculopathy in systemic sclerosis

I Chora, S Guiducci, M Manetti, E Romano… - Autoimmunity …, 2015 - Elsevier
Vascular disease is a hallmark of systemic sclerosis (SSc). It is present in every patient,
being responsible both for the earliest clinical manifestations and the major life-threatening …

[PDF][PDF] Evaluation of endothelial dysfunction and clinical events in patients with early-stage vasculopathy in limited systemic sclerosis

P Jud, A Meinitzer, H Strohmaier… - Clin Exp …, 2021 - clinexprheumatol.org
Objective. Limited cutaneous systemic sclerosis (lcSSc) is characterised by vasculopathy
contributing to vascular apoptosis, structural and functional changes. The aim of this study …

Evaluation of potential serum biomarkers of disease activity in diverse forms of vasculitis

A Rodriguez-Pla, RL Warner, D Cuthbertson… - The Journal of …, 2020 - jrheum.org
Objective. We evaluated potential circulating biomarkers of disease activity in giant cell
arteritis (GCA), Takayasu arteritis (TA), polyarteritis nodosa (PAN), and eosinophilic …

Involvement of functional autoantibodies against vascular receptors in systemic sclerosis

G Riemekasten, A Philippe, M Näther… - Annals of the …, 2011 - ard.bmj.com
Background Systemic sclerosis (SSc) features autoimmunity, vasculopathy and tissue
fibrosis. The renin-angiotensin and endothelin systems have been implicated in …

Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis

J Kluz, W Kopec, U Jakobsche-Policht… - International …, 2009 - search.proquest.com
AIM: Evidence is accumulating for endothelial cell dysfunction as one of the main factors
initiating vessel wall damage in SLE. Enhanced expression of endothelial adhesion …